Gossamer Bio Statistics
NASDAQ: GOSSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.18-0.60 (-5.57%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Gossamer Bio by the numbers
Gossamer Bio has a market capitalization of $62.3 million based on 6.12M shares outstanding. With trailing EPS of $-52.80, Gossamer Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.4% below its 50-day average and 83.5% below its 200-day average.
Average daily trading volume is 376.09K shares, or about $3.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GOSS valuation vs. peer median
| Metric | GOSS | Peer median | Difference |
|---|---|---|---|
| Market cap | $62.26M | $60.88M | +2% |
| Avg. volume | 376.09K | 334.19K | +13% |
Peer median across 8 companies: APLM, RNXT, PLRX, ATHE, BOLD, IBIO, CNTB, XLO.
Valuation
- Market cap
- $62.26M
- EPS (TTM)
- $-52.80
- Shares outstanding
- 6.12M
Price and trading
- Previous close
- 10.78
- Open
- 10.38
- Day range
- 9.77 – 10.66
- 52-week range
- 9.12 – 309.60
- 52-week change
- -94.91%
- Beta
- —
- Volume
- 280.27K
- Average volume
- 376.09K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 62.26M
- Forward Pe
- -0.65
- Eps
- -52.80
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 309.60
- Week52 Low
- 9.12
- Avg Volume
- 376.09K
- Shares Outstanding
- 6.12M
- Ma50
- 12.79
- Ma200
- 61.65
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -96.71%
- Pct From52w Low
- 11.62%